Conbercept for patients with age-related macular degeneration: a systematic review

BACKGROUND: Conbercept is a novel vascular endothelial growth factor (VEGF) inhibitor for the treatment of wet age-related macular degeneration (AMD). This systematic review aims to assess the efficacy and safety of conbercept in the treatment of wet AMD. METHODS: PubMed, Embase, Cochrane Library, C...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jiaxing, Liang, Yi, Xie, Juan, Li, Dong, Hu, Qian, Li, Xiaosi, Zheng, Wenyi, He, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003117/
https://www.ncbi.nlm.nih.gov/pubmed/29902977
http://dx.doi.org/10.1186/s12886-018-0807-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003117/
https://www.ncbi.nlm.nih.gov/pubmed/29902977
http://dx.doi.org/10.1186/s12886-018-0807-1

Ejemplares similares